Family-Initiated Interpretation in the PICU

NCT ID: NCT05791240

Last Updated: 2024-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

292 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-03

Study Completion Date

2024-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to compare interpreter use rates before and after allowing non-English speaking families to call an interpreter themselves. The main questions it aims to answer are:

Is it feasible for families to call an interpreter themselves? Will allowing families to call an interpreter themselves increase the rate of professional interpreter utilization?

Participants will be given an interpreting tablet and instructed to use the interpreter application whenever they would like to talk to the medical team. There will be a short survey on the feasibility and acceptability of the intervention for the patients and the medical team. The study team will then look at interpreter use rates before and after the intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

More than 25 million people in the United States have limited English proficiency. Patients with limited English proficiency face worse clinical outcomes than their English proficient counterparts, like longer length of stays, increased adverse events, and decreased understanding of their child's care. Language barriers may be particularly important in the pediatric intensive care unit (PICU), where parents encounter challenging medical decisions like choosing to pursue high-risk therapies or making end-of-life decisions.

Professional interpretation has been shown to mitigate negative outcomes for this population. For instance, one study showed decreased mortality in the pediatric intensive care unit (PICU) for Latino patients after in-person interpreter availability was increased; however, interpreters are still widely underutilized. One study in a PICU revealed that only 53% of doctors and 41% of nurses used an interpreter "often" for their patients who needed it. To improve clinical outcomes for this population, communication with patients with LEP needs to be improved.

Health disparities as a result of limited English proficiency are unjust, and a just medical system would allow patients with LEP to access the same quality of care as their English-proficiency counterparts. One way to improve communication may be to provide families with an opportunity to initiate interpreter use on their own. Although families have expressed a desire for this, no previous studies have examined the effects of this strategy.

Hypothesis:

The study team hypothesizes that implementing a novel family-initiated interpretation system will lead to greater use of interpreters, compared to the current standard of care. The investigators plan to test this hypothesis in the PICU. The specific aims are:

Explore the feasibility, usability, and acceptability of a family-initiated interpreter intervention among healthcare providers, and the acceptability of the intervention among families with limited English proficiency.

Examine the impact of family-initiated interpretation intervention on professional interpreter utilization by comparing pre and post-intervention professional interpreter utilization rates in the PICU.

By allowing families to initiate contact with an interpreter, the study team believe that interpreter utilization will increase, with the potential to decrease disparities in the limited English proficiency population. This work will inform future work to improve care for patients with limited English proficiency, and the investigators plan to investigate the clinical impact of this interpreter modality in future projects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Limited English Proficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pre-Intervention

The medical team will use standard interpreter practices with this group.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventional

This arm will be given interpreter tablets in order to allow them to call interpreter themselves.

Group Type EXPERIMENTAL

Family Initiated Interpretation

Intervention Type BEHAVIORAL

Interpreter tablet will be given to families so they can contact an interpreter themselves.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Family Initiated Interpretation

Interpreter tablet will be given to families so they can contact an interpreter themselves.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients and families admitted to the pediatric intensive care unit (PICU) whose family requires an interpreter

Exclusion Criteria

* Patients and families who do not require interpretation
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwestern University Feinberg School of Medicine

OTHER

Sponsor Role collaborator

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mary Pilarz, MD

Role: PRINCIPAL_INVESTIGATOR

Ann and Robert H. Lurie Children's Hospital of Chicago

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-5221

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.